Young At Heart Pueblo Kids Vision - Medicare Optometrist in Pueblo, CO

Young At Heart Pueblo Kids Vision is a medicare enrolled "Optometrist" provider in Pueblo, Colorado. Their current practice location is 2568 Taylor Ln, Pueblo, Colorado. You can reach out to their office (for appointments etc.) via phone at (719) 696-9009.

Young At Heart Pueblo Kids Vision is licensed to practice in Colorado (license number OPT0002072) and it also participates in the medicare program. Young At Heart Pueblo Kids Vision is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1417461823.

Contact Information

Young At Heart Pueblo Kids Vision
2568 Taylor Ln,
Pueblo, CO 81005
(719) 696-9009
Not Available



Healthcare Provider's Profile

Full NameYoung At Heart Pueblo Kids Vision
TypeFacility
SpecialityOptometrist
Location2568 Taylor Ln, Pueblo, Colorado
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1417461823
  • Provider Enumeration Date: 11/21/2017
  • Last Update Date: 07/05/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 8628328010
  • Enrollment ID: O20180905003243

Medical Identifiers

Medical identifiers for Young At Heart Pueblo Kids Vision such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1417461823NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist OPT0002072 (Colorado)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Young At Heart Pueblo Kids Vision acts as a billing entity for following providers:
Provider NameSteven A Loomis
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1063470144
PECOS PAC ID: 2163325564
Enrollment ID: I20100504000885

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameLee Shuwarger
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1306856141
PECOS PAC ID: 0143384156
Enrollment ID: I20180913001775

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameScott Bartlett
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1639458979
PECOS PAC ID: 4981875572
Enrollment ID: I20181015000212

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameJacqueline Evans
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1053726315
PECOS PAC ID: 4587997473
Enrollment ID: I20190607001948

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameKaren Mohar Sanghera
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1467884817
PECOS PAC ID: 0446477798
Enrollment ID: I20220302000637

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameVan-anh Huynh
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1770036212
PECOS PAC ID: 4688072622
Enrollment ID: I20220302001065

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NamePhilip Potts
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1952449837
PECOS PAC ID: 3375648660
Enrollment ID: I20220311000024

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameBrian Anderson
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1356436661
PECOS PAC ID: 1759316631
Enrollment ID: I20220322000249

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameSamuel Cox
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1972608974
PECOS PAC ID: 2264524503
Enrollment ID: I20220323001973

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameMalay Pansheria
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1821471657
PECOS PAC ID: 4082904214
Enrollment ID: I20220401000396

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameBrian Lewy
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1750379087
PECOS PAC ID: 5597089011
Enrollment ID: I20230105002423

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameDana Hobi
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1619590403
PECOS PAC ID: 3779966551
Enrollment ID: I20230403001034

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameJoseph Pruitt
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1477752913
PECOS PAC ID: 8921187477
Enrollment ID: I20230414000908

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameDena Shahani
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1134533953
PECOS PAC ID: 8123404274
Enrollment ID: I20230506000317

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NamePriscilla Lee
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1235126129
PECOS PAC ID: 5092790592
Enrollment ID: I20230518003534

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Provider NameRonald Meeker
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1194728188
PECOS PAC ID: 9032000286
Enrollment ID: I20230605000305

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Young At Heart Pueblo Kids Vision is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Young At Heart Pueblo Kids Vision
2041 Pepper Ln,
Pueblo, CO 81005-3276

Ph: (719) 696-9009
Young At Heart Pueblo Kids Vision
2568 Taylor Ln,
Pueblo, CO 81005

Ph: (719) 696-9009

News Archive

Researchers investigate effects of nanoparticles on yeast

Nanoparticles are already widely used in everyday products such as cosmetics, textiles, dyes, and paints. It is quite possible that these minute fragments of matter may in future not only come to play a crucial role in medicine and pharmacology, but also in the food and biotechnology industries. The latest research currently being conducted in India has shown that nanoparticles can promote the growth of fungi and even assist plant growth.

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics' three currently available diagnostic tests.

Six key factors determine medication adherence in people with bipolar disorder

People with bipolar disorder may not take their medication because of side effects, fear of addiction and a preference for alternative treatment - according to research from Norfolk and Suffolk NHS Foundation Trust (NSFT) and the University of East Anglia (UEA).

Read more News

› Verified 6 days ago


Optometrist in Pueblo, CO

Dr Robert K Browder Optometrist
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 415 N Greenwood St, Ste F, Pueblo, CO 81003
Phone: 719-561-4365    Fax: 719-542-2140
Hv Pueblo South Llc
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1725 S Pueblo Blvd, Pueblo, CO 81005
Phone: 719-281-2633    
Dr. Michael R. Cozzetta, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1620 Fortino Blvd, Pueblo, CO 81008
Phone: 719-542-3555    Fax: 719-542-0776
Dr. Aaron Ransome & Associates P.c.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 1700 W Us Highway 50, Pueblo, CO 81008
Phone: 719-404-5000    
Dr. Dale Allen Knudson, O.D.
Optometrist
Medicare: Medicare Enrolled
Practice Location: 900 Indiana Ave, Suite # D, Pueblo, CO 81004
Phone: 719-561-2812    
Dr. Cory W Smith, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 27 Montebello Rd, Pueblo, CO 81001
Phone: 719-545-1530    Fax: 719-545-2899
Rocky Mountain Eye Center Inc A Colorado Provider Network
Optometrist
Medicare: Medicare Enrolled
Practice Location: 27 Montebello Rd, Pueblo, CO 81001
Phone: 719-545-1530    Fax: 719-545-2899

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.